Circadian fluctuations in efficacy of streptokinase thrombolysis

Harefuah

Volumn 136, Issue 6, 1999, Pages

  Goldhammer, E ^a   Kharash, L ^a   Abinader, E G ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE;

ARTICLE; CIRCADIAN RHYTHM; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; THROMBOSIS;

EID: 0033559129     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Muller JE, Stone PH, Turi ZG & al, the MILIS Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med, 1985; 313: 1315-1322.
2. WHO International Study Group. Myocardial infarction community registries: public health in Europe. Copenhagen. 1976; 5: 1-232.
3. Pell S & D'Alonzo CA, Acute myocardial infarction in a large industrial population: report of a 6-year study of 1,356 cases. JAMA, 1963; 185: 831-838.
4. Thompson DR, Blandford RL, Sutton TW & al, Time of onset of chest pain in acute myocardial infarction. Int J Cardiol, 1985; 7: 139-46.
5. Andreotti F, Davies GJ, Hackett DR & al, Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol, 1988; 62: 635-637.
6. Toffler GH, Brezinsky D, Schafer AI & al, Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med, 1987; 316: 1514-1518.
7. Masuda T, Ogawa H, Miyao Y & al, Circadian variation in fibrinolytic activity in patients with variant angina. Br Heart J, 1994; 71: 156-161.
8. Tzivoni D, Circadian variations in total ischemic burden and ischemic threshold. Eur Heart J, 1996; 17 (suppl GP): 59-63.
9. Asmar R, Benetos A, Pannier B & al, Prevalence and circadian variations of S-T segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension. Am J Cardiol, 1996; 77: 384-390.
10. Abinader EG, Sharif D & Goldhammer E, Attenuation of the circadian S-T depression with propranolol in mitral valve prolapse. Am J Cardiol, 1994; 73: 914-916.
11. Petralito A, Mangiafico RA, Gibbino S & al, Daily modifications of plasma fibrinogen, platelet aggregation, Howells time, PTT, TT, and antithrombin III in normal subjects and in patients with vascular disease. Chronobiologica, 1982; 9: 195-201.
12. Huber K, Rose D, Resch I & al, Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb Haemostas, 1988; 60: 372-376.
13. Kurnik PB, Circadian variation in the efficacy of tissue type plasminogen activator. Circulation, 1995; 91: 1341-1346.
14. Becker RC, Corrao JM, Baker SP & al, Circadian variation in thrombolytic response to recombinant tissue-type plasminogen activator in acute myocardial infarction. J Appl Cardiol, 1988; 32: 213-221.
15. Kono T, Morita H, Nishina T & al, Circadian variations in the onset of acute myocardial infarction and efficacy of thrombolytic therapy. JACC, 1996; 27: 774-778.
16. Norris RM ,White HD, Cross DB & al, Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis. Br Heart J, 1993; 69: 485-491.
17. Fernandez AR, Sequeira RF, Chakko S & al, ST segment tracking for rapid determination of patency of the infarct related artery in acute myocardial infarction. J Am Coll Cardiol, 1995; 26: 675-683.
18. Langer A, Krucoff MW, Klutwijk P & al, Non-invasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. J Am Coll Cardiol, 1995; 25: 1552-1557.